Home » Topics » Conferences

Conferences
RSS

Review of the preclinical activity of GAR-936, a glycylcycline antibiotic with clinical potential

Oct. 2, 1998

MC-02479/RWJ-54428: in vitro activity and pharmacokinetics in animals

Oct. 1, 1998

Results from human pharmacokinetic studies support once-daily dosing for MK-991

Oct. 1, 1998

MEN-10700 highly active against pneumococci, gonococci and meningococci

Oct. 1, 1998

Promising new rhinovirus 3C protease inhibitor emerges from Agouron R&D

Oct. 1, 1998

Comparative in vitro antipneumococcal activity of CFC-222 presented at ICAAC

Oct. 1, 1998

ICAAC presentation for potent new anti-HCMV agent from RPR with novel mechanism of action

Oct. 1, 1998

Twice-daily Viracept as safe and effective as the approved t.i.d. schedule

Oct. 1, 1998

Major pediatric study supports safety and efficacy of pneumococcal vaccine

Oct. 1, 1998

Aviron presents new clinical data for FluMist at ICAAC

Oct. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...